Drug Shortage Report for PRIVA-ATORVASTATIN

Last updated on 2021-08-03 History
Report ID 124227
Drug Identification Number 02482916
Brand name PRIVA-ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name PHARMAPAR INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-09-14
Estimated end date 2021-02-04
Actual end date 2021-03-27
Shortage status Resolved
Updated date 2021-08-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1565 BOUL LIONEL-BOULET
VARENNES, QUEBEC
CANADA J3X 1P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-08-03 French Compare
v12 2021-08-03 English Compare
v11 2021-02-05 French Compare
v10 2021-02-05 English Compare
v9 2021-01-22 French Compare
v8 2021-01-22 English Compare
v7 2020-12-15 French Compare
v6 2020-12-15 English Compare
v5 2020-11-13 French Compare
v4 2020-11-13 English Compare
v3 2020-09-15 English Compare
v2 2020-09-14 French Compare
v1 2020-09-14 English Compare

Showing 1 to 13 of 13